Liposome Drug Delivery Market - Top Companies and Manufacturers

Market Definition
1. Definition
2. Market Segmentation
Assumptions and Acronyms
Research Methodology
1. Research Process
2. Primary Research
3. Secondary Research
Executive Summary – Global Liposome Drug Delivery Market
Market Dynamics
1. Drivers
2. Challenges
3. Trends
4. Opportunities
Pipeline Analysis
Clinically Marketed Liposome Drugs
Regulatory Scenario Assessment
Analysis on Lipid Nanoparticles
Competitive Landscape
1. Market Share Analysis, 2021
2. Company Profiles
  1. Pharmaceutical Formulation Manufacturers
    1. Spectrum Pharmaceuticals, Inc.
    2. Gilead Sciences, Inc.
    3. Celsion Corporation
    4. Ipsen Pharma
    5. Pacira Pharmaceuticals, Inc.
    6. Novartis AG
    7. CordenPharma International
    8. FUJIFILM Toyama Chemical Co., Ltd.
    9. Takeda Pharmaceutical Company Limited
    10. Johnson & Johnson Services, Inc.
    11. Astellas Pharma Inc.
    12. Elan Pharmaceuticals (Perrigo Company plc)
    13. Merrimack Pharmaceuticals, Inc.
    14. Janssen Pharmaceuticals, Inc.
  2. Raw Material Manufacturers
    1. NIPPON FINE CHEMICAL CO., LTD.
    2. Sonic Biochem Extractions Pvt. Ltd.
    3. Croda International Plc
    4. Lipoid GmbH
    5. Hashimoto Electronic Industry Co., LTD
Global Liposome Drug Delivery Market
1. Market Overview
2. Market Size (2021-2031)
3. Market Segmentation by:
  1. Product
    1. Liposomal Doxorubicin, 2021-2031F (USD Million)
    2. Liposomal Paclitaxel, 2021-2031F (USD Million)
    3. Liposomal Amphotericin, 2021-2031F (USD Million)
    4. Others, 2021-2031F (USD Million)
  2. Technology
    1. Stealth Liposome Technology, 2021-2031F (USD Million)
    2. Non-PEGylated Liposome Technology, 2021-2031F (USD Million)
    3. DepoFoam Liposome Technology, 2021-2031F (USD Million)
  3. Application
    1. Fungal Diseases, 2021-2031F (USD Million)
    2. Pain Management, 2021-2031F (USD Million)
    3. Cancer Therapy, 2021-2031F (USD Million)
    4. Viral Vaccines, 2021-2031F (USD Million)
    5. Photodynamic Therapy, 2021-2031F (USD Million)
    6. Others, 2021-2031F (USD Million)
  4. Region
    1. North America, 2021-2031F (USD Million)
    2. Europe, 2021-2031F (USD Million)
    3. Asia Pacific, 2021-2031F (USD Million)
    4. Latin America, 2021-2031F (USD Million)
    5. Middle East & Africa, 2021-2031F (USD Million)
North America Liposome Drug Delivery Market
1. Market Overview
2. Market Size (2021-2031)
3. Market Segmentation by:
  1. Product
    1. Liposomal Doxorubicin, 2021-2031F (USD Million)
    2. Liposomal Paclitaxel, 2021-2031F (USD Million)
    3. Liposomal Amphotericin, 2021-2031F (USD Million)
    4. Others, 2021-2031F (USD Million)
  2. Technology
    1. Stealth Liposome Technology, 2021-2031F (USD Million)
    2. Non-PEGylated Liposome Technology, 2021-2031F (USD Million)
    3. DepoFoam Liposome Technology, 2021-2031F (USD Million)
  3. Application
    1. Fungal Diseases, 2021-2031F (USD Million)
    2. Pain Management, 2021-2031F (USD Million)
    3. Cancer Therapy, 2021-2031F (USD Million)
    4. Viral Vaccines, 2021-2031F (USD Million)
    5. Photodynamic Therapy, 2021-2031F (USD Million)
    6. Others, 2021-2031F (USD Million)
  4. Country
    1. United States, 2021-2031F (USD Million)
    2. Canada, 2021-2031F (USD Million)
Europe Liposome Drug Delivery Market
1. Market Overview
2. Market Size (2021-2031)
3. Market Segmentation by:
  1. Product
  2. Technology
  3. Application
  4. Country
    1. Germany, 2021-2031F (USD Million)
    2. United Kingdom, 2021-2031F (USD Million)
    3. France, 2021-2031F (USD Million)
    4. Italy, 2021-2031F (USD Million)
    5. Spain, 2021-2031F (USD Million)
    6. Rest of Europe, 2021-2031F (USD Million)
Asia Pacific Liposome Drug Delivery Market
1. Market Overview
2. Market Size (2021-2031)
3. Market Segmentation by:
  1. Product
  2. Technology
  3. Application
  4. Country
    1. China, 2021-2031F (USD Million)
    2. India, 2021-2031F (USD Million)
    3. Japan, 2021-2031F (USD Million)
    4. Australia, 2021-2031F (USD Million)
    5. New Zealand, 2021-2031F (USD Million)
    6. Rest of APAC, 2021-2031F (USD Million)
Latin America Liposome Drug Delivery Market
1. Market Overview
2. Market Size (2021-2031)
3. Market Segmentation by:
  1. Product
  2. Technology
  3. Application
  4. Country
    1. Brazil, 2021-2031F (USD Million)
    2. Mexico, 2021-2031F (USD Million)
    3. Rest of LATAM, 2021-2031F (USD Million)
Middle East & Africa Liposome Drug Delivery Market
1. Market Overview
2. Market Size (2021-2031)
3. Market Segmentation by:
  1. Product
  2. Technology
  3. Application
  4. Country
    1. GCC, 2021-2031F (USD Million)
    2. South Africa, 2021-2031F (USD Million)
    3. Rest of MEA, 2021-2031F (USD Million)

Companies Dominating the Liposome Drug Delivery Landscape

Spectrum Pharmaceuticals, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Gilead Sciences, Inc.
Celsion Corporation
Ipsen Pharma
Pacira Pharmaceuticals, Inc.
Novartis AG
CordenPharma International
FUJIFILM Toyama Chemical Co., Ltd.
Takeda Pharmaceutical Company Limited
Johnson & Johnson Services, Inc.

Browse Key Market Insights with Data Illustration:

Liposome Drug Delivery Market Size & Share, Growth Forecasts 2036

In the News

Endo Ventures Limited (EVL), a subsidiary of Endo International plc, agreed with Taiwan Liposome Company, Ltd. (TLC), a clinical-stage specialty pharmaceutical company, will commercialize his TLC product, TLC599, which is under investigation. TLC599 is an injectable compound in Phase III development for the treatment of knee osteoarthritis knee pain.
Pfizer and Acuitas Therapeutics entered into a Development and Options Agreement. This gives Pfizer the option to license Aquinas lipid nanoparticle (LNP) technology non-exclusively for up to 10 vaccine targets or therapeutics development.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of liposome drug delivery is evaluated at USD 5.91 Billion.

The liposome drug delivery market size was over USD 5.46 Billion in 2023 and is likely to exceed USD 17.14 Billion by the end of 2036, growing at over 9.2% CAGR during the forecast period i.e., between 2024-2036. The rising prevalence of cancer globally, and the increasing application of liposomes as a drug delivery system are some of the major factors anticipated to drive market growth.

North America is expected to garner the largest revenue of 45% by 2036, impelled by increasing prevalence of cancer in the region.

Spectrum Pharmaceuticals, Inc., Gilead Sciences, Inc., Celsion Corporation, Ipsen Pharma, Pacira Pharmaceuticals, Inc., Novartis AG, CordenPharma International, FUJIFILM Toyama Chemical Co., Ltd., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc.

Liposome Drug Delivery Market - Top Companies and Manufacturers

Companies Dominating the Liposome Drug Delivery Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the liposome drug delivery market market?

What are the factors driving the liposome drug delivery market landscape?

Which region held the largest liposome drug delivery market industry share?

Who are the key players in the liposome drug delivery market sector?